Sensorion to launch gene therapy trial of SENS-501 for hearing loss in France
Sensorion, a leading clinical-stage biotechnology company, has achieved a major milestone in the field of audiology and genetic research. The company has received approval for ... Read More
Sensorion OTOF-GT gene therapy candidate gets FDA rare pediatric designation
Sensorion, a French biotechnology company, has received the rare pediatric disease designation from the US Food and Drug Administration (FDA) for its OTOF-GT gene therapy ... Read More
Sensorion gets FDA nod for SENS-401 trial for inner ear condition
French inner ear diseases company Sensorion has secured the investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to move ahead ... Read More